COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABBVIE INC | COM | 00287Y109 | 217,784 | 1,608,451 | SH | | OTR | | 1,608,451 | 0 | 0 |
ADOBE SYSTEMS INCORPORATED | COM | 00724F101 | 213,215 | 376,000 | SH | | OTR | | 376,000 | 0 | 0 |
AGILE GROWTH CORP | CLASS A ORD | G01202103 | 11,640 | 1,200,000 | SH | | OTR | | 1,200,000 | 0 | 0 |
AGILE GROWTH CORP | *W EXP 03/09/202 | G01202111 | 256 | 399,999 | SH | | OTR | | 399,999 | 0 | 0 |
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 41,304 | 1,256,578 | SH | | OTR | | 1,256,578 | 0 | 0 |
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 201,805 | 1,190,028 | SH | | OTR | | 1,190,028 | 0 | 0 |
ALPHABET INC | CAP STK CL C | 02079K107 | 662,508 | 228,957 | SH | | OTR | | 228,957 | 0 | 0 |
ALTC ACQUISITION CORP | COM CL A | 02156V109 | 968 | 98,300 | SH | | OTR | | 98,300 | 0 | 0 |
AMYRIS INC | COM NEW | 03236M200 | 58,752 | 10,859,811 | SH | | OTR | | 10,859,811 | 0 | 0 |
ANNEXON INC | COM | 03589W102 | 5,260 | 457,764 | SH | | OTR | | 457,764 | 0 | 0 |
ANTHEM INC | COM | 036752103 | 350,001 | 755,060 | SH | | OTR | | 755,060 | 0 | 0 |
AON PLC | SHS CL A | G0403H108 | 358,714 | 1,193,486 | SH | | OTR | | 1,193,486 | 0 | 0 |
APOLLO STRATEGIC GRWT CPTL II | SHS CL A | G0412A102 | 7,335 | 750,000 | SH | | OTR | | 750,000 | 0 | 0 |
APOLLO STRATEGIC GRWT CPTL II | *W EXP 02/12/202 | G0412A128 | 143 | 150,000 | SH | | OTR | | 150,000 | 0 | 0 |
ARAMARK | COM | 03852U106 | 661,917 | 17,962,483 | SH | | OTR | | 17,962,483 | 0 | 0 |
ARCLIGHT CLEAN TRANSITION II | CLASS A ORD SHS | G0R21B104 | 7,485 | 750,000 | SH | | OTR | | 750,000 | 0 | 0 |
ARCLIGHT CLEAN TRANSITION II | *W EXP 03/16/202 | G0R21B112 | 251 | 150,000 | SH | | OTR | | 150,000 | 0 | 0 |
ARCTOS NORTHSTAR ACQUIS CORP | SHS CL A | G0477L100 | 1,949 | 200,000 | SH | | OTR | | 200,000 | 0 | 0 |
ARCTOS NORTHSTAR ACQUIS CORP | *W EXP 99/99/999 | G0477L126 | 40 | 50,000 | SH | | OTR | | 50,000 | 0 | 0 |
ARES ACQUISITION CORPORATION | *W EXP 99/99/999 | G33032122 | 178 | 200,000 | SH | | OTR | | 200,000 | 0 | 0 |
ARES ACQUISITION CORPORATION | COM CL A | G33032106 | 13,880 | 1,425,000 | SH | | OTR | | 1,425,000 | 0 | 0 |
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 21,257 | 320,617 | SH | | OTR | | 320,617 | 0 | 0 |
ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 7,944 | 800,000 | SH | | OTR | | 800,000 | 0 | 0 |
ARYA SCIENCES ACQUISITN CORP V | CLASS A ORD SHS | G31658100 | 7,219 | 745,000 | SH | | OTR | | 745,000 | 0 | 0 |
ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 111,034 | 1,906,155 | SH | | OTR | | 1,906,155 | 0 | 0 |
ATENTO S A | SHS | L0427L204 | 56,941 | 2,230,357 | SH | | OTR | | 2,230,357 | 0 | 0 |
AUSTERLITZ ACQUISITION CORP | SHS CL A | G0633D109 | 24,275 | 2,500,000 | SH | | OTR | | 2,500,000 | 0 | 0 |
AUSTERLITZ ACQUISITION CORP | *W EXP 02/19/202 | G0633D125 | 131 | 125,000 | SH | | OTR | | 125,000 | 0 | 0 |
AUSTERLITZ ACQUISITION CORP II | COM CL A | G0633U101 | 14,580 | 1,500,000 | SH | | OTR | | 1,500,000 | 0 | 0 |
AUSTERLITZ ACQUISITION CORP II | *W EXP 02/19/202 | G0633U127 | 367 | 375,000 | SH | | OTR | | 375,000 | 0 | 0 |
AVANTOR INC | COM | 05352A100 | 153,510 | 3,642,858 | SH | | OTR | | 3,642,858 | 0 | 0 |
AVITA MEDICAL INC | COM | 05380C102 | 9,584 | 800,000 | SH | | OTR | | 800,000 | 0 | 0 |
AVROBIO INC | COM | 05455M100 | 2,849 | 740,000 | SH | | OTR | | 740,000 | 0 | 0 |
BEAM THERAPEUTICS INC | COM | 07373V105 | 180,501 | 2,265,045 | SH | | OTR | | 2,265,045 | 0 | 0 |
BERENSON ACQUISITION CORP I | CL A COM | 083690107 | 23,933 | 2,475,000 | SH | | OTR | | 2,475,000 | 0 | 0 |
BERENSON ACQUISITION CORP I | *W EXP 08/01/202 | 083690115 | 625 | 1,237,500 | SH | | OTR | | 1,237,500 | 0 | 0 |
BERKELEY LTS INC | COM | 084310101 | 14,314 | 787,327 | SH | | OTR | | 787,327 | 0 | 0 |
BETTER THERAPEUTICS INC | COMMON STOCK | 08773T104 | 6,278 | 1,350,000 | SH | | OTR | | 1,350,000 | 0 | 0 |
BHP GROUP PLC | SPONSORED ADR | 05545E209 | 405,539 | 6,785,000 | SH | | OTR | 1 | 6,785,000 | 0 | 0 |
BIG SKY GROWTH PARTNERS INC | CLASS A COM | 08954L102 | 15,051 | 1,550,000 | SH | | OTR | | 1,550,000 | 0 | 0 |
BIG SKY GROWTH PARTNERS INC | *W EXP 04/01/202 | 08954L110 | 279 | 387,500 | SH | | OTR | | 387,500 | 0 | 0 |
BIOGEN INC | COM | 09062X103 | 35,438 | 147,709 | SH | | OTR | | 147,709 | 0 | 0 |
BLACKSTONE INC | COM | 09260D107 | 309,933 | 2,395,336 | SH | | OTR | | 2,395,336 | 0 | 0 |
BLOCKCHAIN COINVSTRS ACQ CRP | UNIT 09/01/2026 | G11765123 | 3,033 | 300,000 | SH | | OTR | | 300,000 | 0 | 0 |
BLUE WHALE ACQUISITION CORP | CLASS A ORD SHS | G1330M103 | 5,572 | 575,000 | SH | | OTR | | 575,000 | 0 | 0 |
BLUE WHALE ACQUISITION CORP | *W EXP 07/30/202 | G1330M129 | 122 | 143,750 | SH | | OTR | | 143,750 | 0 | 0 |
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 86,946 | 811,747 | SH | | OTR | | 811,747 | 0 | 0 |
BOSTON SCIENTIFIC CORP | COM | 101137107 | 714,283 | 16,814,581 | SH | | OTR | | 16,814,581 | 0 | 0 |
BROADCOM INC | COM | 11135F101 | 320,062 | 481,000 | SH | | OTR | | 481,000 | 0 | 0 |
BROADMARK RLTY CAP INC | COM | 11135B100 | 45,736 | 4,850,000 | SH | | OTR | | 4,850,000 | 0 | 0 |
BROADMARK RLTY CAP INC | *W EXP 11/15/202 | 11135B118 | 636 | 7,174,613 | SH | | OTR | | 7,174,613 | 0 | 0 |
BROADSCALE ACQUISITION CORP | COM CL A | 11134Y101 | 2,485 | 250,000 | SH | | OTR | | 250,000 | 0 | 0 |
BRUKER CORP | COM | 116794108 | 62,535 | 745,266 | SH | | OTR | | 745,266 | 0 | 0 |
CARA THERAPEUTICS INC | COM | 140755109 | 24,360 | 2,000,000 | SH | | OTR | | 2,000,000 | 0 | 0 |
CARIBOU BIOSCIENCES INC | COM | 142038108 | 44,718 | 2,963,448 | SH | | OTR | | 2,963,448 | 0 | 0 |
CASCADE ACQUISITION CORP | COM CL A | 147151104 | 9,841 | 990,000 | SH | | OTR | | 990,000 | 0 | 0 |
CASCADE ACQUISITION CORP | *W EXP 11/30/202 | 147151112 | 247 | 495,000 | SH | | OTR | | 495,000 | 0 | 0 |
CATALENT INC | COM | 148806102 | 97,759 | 763,561 | SH | | OTR | | 763,561 | 0 | 0 |
CATALYST PARTNRS ACQUISITN C | CLASS A ORD SHS | G19550105 | 8,139 | 835,638 | SH | | OTR | | 835,638 | 0 | 0 |
CATALYST PARTNRS ACQUISITN C | *W EXP 05/12/202 | G19550121 | 130 | 150,780 | SH | | OTR | | 150,780 | 0 | 0 |
CENTENE CORP DEL | COM | 15135B101 | 357,562 | 4,339,344 | SH | | OTR | | 4,339,344 | 0 | 0 |
CHARTER COMMUNICATIONS INC N | CL A | 16119P108 | 205,828 | 315,701 | SH | | OTR | | 315,701 | 0 | 0 |
CHEMOCENTRYX INC | COM | 16383L106 | 34,060 | 935,463 | SH | | OTR | | 935,463 | 0 | 0 |
CHURCHILL CAPITAL CORP VI | COM CL A | 17143W101 | 7,655 | 782,767 | SH | | OTR | | 782,767 | 0 | 0 |
CHURCHILL CAPITAL CORP VI | *W EXP 02/17/202 | 17143W119 | 82 | 80,000 | SH | | OTR | | 80,000 | 0 | 0 |
CHURCHILL CAPITAL CORP VII | COM CL A | 17144M102 | 9,830 | 1,000,000 | SH | | OTR | | 1,000,000 | 0 | 0 |
CHURCHILL CAPITAL CORP VII | *W EXP 02/29/202 | 17144M110 | 200 | 200,000 | SH | | OTR | | 200,000 | 0 | 0 |
CLEVER LEAVES HOLDINGS INC | COM | 186760104 | 7,266 | 2,343,767 | SH | | OTR | | 2,343,767 | 0 | 0 |
CLEVER LEAVES HOLDINGS INC | COM | 186760104 | 2,189 | 706,086 | SH | | OTR | | 706,086 | 0 | 0 |
CLOVIS ONCOLOGY INC | NOTE 1.250% 5/0 | 189464AC4 | 36,467 | 51,910,000 | PRN | | OTR | | 51,910,000 | 0 | 0 |
COGENT BIOSCIENCES INC | COM | 19240Q201 | 5,148 | 600,000 | SH | | OTR | | 600,000 | 0 | 0 |
COLONNADE ACQUISITION CORP II | SHS CL A | G2284B101 | 4,855 | 500,000 | SH | | OTR | | 500,000 | 0 | 0 |
COLONNADE ACQUISITION CORP II | *W EXP 99/99/999 | G2284B119 | 72 | 100,000 | SH | | OTR | | 100,000 | 0 | 0 |
COMPASS THERAPEUTICS INC | COM | 20454B104 | 3,170 | 1,000,000 | SH | | OTR | | 1,000,000 | 0 | 0 |
CORAZON CAPITAL V838 MONOCER | CLASS A ORD SHS | G24237102 | 9,785 | 1,000,000 | SH | | OTR | | 1,000,000 | 0 | 0 |
CORAZON CAPITAL V838 MONOCER | *W EXP 03/24/202 | G24237128 | 230 | 333,334 | SH | | OTR | | 333,334 | 0 | 0 |
CORSAIR PARTNERING CORP | SHS CL A | G2540H108 | 6,832 | 700,000 | SH | | OTR | | 700,000 | 0 | 0 |
CORSAIR PARTNERING CORP | *W EXP 07/06/202 | G2540H116 | 236 | 233,330 | SH | | OTR | | 233,330 | 0 | 0 |
CRYPTO 1 ACQUISITION CORP | UNIT 04/30/2028 | G3168A128 | 1,010 | 100,000 | SH | | OTR | | 100,000 | 0 | 0 |
CVS HEALTH CORP | COM | 126650100 | 132,195 | 1,281,456 | SH | | OTR | | 1,281,456 | 0 | 0 |
CYTOKINETICS INC | COM NEW | 23282W605 | 98,924 | 2,170,342 | SH | | OTR | | 2,170,342 | 0 | 0 |
DARIOHEALTH CORP | COM NEW | 23725P209 | 7,004 | 540,000 | SH | | OTR | | 540,000 | 0 | 0 |
DISRUPTIVE ACQUISITION CORP | CLASS A ORD SHS | G2770Y102 | 13,720 | 1,400,000 | SH | | OTR | | 1,400,000 | 0 | 0 |
DISRUPTIVE ACQUISITION CORP | *W EXP 03/06/202 | G2770Y128 | 373 | 466,667 | SH | | OTR | | 466,667 | 0 | 0 |
DRAGONEER GROWTH OPT CORP III | CL A SHS | G28315102 | 4,736 | 484,709 | SH | | OTR | | 484,709 | 0 | 0 |
ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 117,691 | 1,573,829 | SH | | OTR | | 1,573,829 | 0 | 0 |
EQRX INC | *W EXP 12/17/202 | 26886C115 | 156 | 150,000 | SH | | OTR | | 150,000 | 0 | 0 |
EQUIFAX INC | COM | 294429105 | 294,308 | 1,005,183 | SH | | OTR | | 1,005,183 | 0 | 0 |
EXACT SCIENCES CORP | COM | 30063P105 | 25,053 | 321,898 | SH | | OTR | | 321,898 | 0 | 0 |
EXELIXIS INC | COM | 30161Q104 | 161,945 | 8,859,157 | SH | | OTR | | 8,859,157 | 0 | 0 |
EXSCIENTIA PLC | ADS | 30223G102 | 8,398 | 425,000 | SH | | OTR | | 425,000 | 0 | 0 |
FATE THERAPEUTICS INC | COM | 31189P102 | 44,317 | 757,425 | SH | | OTR | | 757,425 | 0 | 0 |
FIBROGEN INC | COM | 31572Q808 | 12,960 | 919,117 | SH | | OTR | | 919,117 | 0 | 0 |
FIFTH WALL ACQUISITN CORP III | CLASS A ORD SHS | G34142102 | 13,532 | 1,360,040 | SH | | OTR | | 1,360,040 | 0 | 0 |
FINSERV ACQUISITION CORP II | COM CL A | 31809Y103 | 5,832 | 600,000 | SH | | OTR | | 600,000 | 0 | 0 |
FINSERV ACQUISITION CORP II | *W EXP 02/17/202 | 31809Y111 | 93 | 150,000 | SH | | OTR | | 150,000 | 0 | 0 |
FIRST RESERVE SUSTAINABLE GW | CLASS A COM | 336169107 | 3,960 | 400,000 | SH | | OTR | | 400,000 | 0 | 0 |
FIRST RESERVE SUSTAINABLE GW | *W EXP 03/05/202 | 336169115 | 82 | 100,000 | SH | | OTR | | 100,000 | 0 | 0 |
FOREST ROAD ACQUISITION COR II | CL A | 34619V103 | 12,163 | 1,250,000 | SH | | OTR | | 1,250,000 | 0 | 0 |
FOREST ROAD ACQUISITION COR II | *W EXP 01/15/202 | 34619V111 | 195 | 250,000 | SH | | OTR | | 250,000 | 0 | 0 |
FORTRESS VALUE ACQUISI CORP IV | COM CL A | 34964K108 | 17,063 | 1,750,000 | SH | | OTR | | 1,750,000 | 0 | 0 |
FORTRESS VALUE ACQUISI CORP IV | *W EXP 03/18/202 | 34964K116 | 184 | 218,748 | SH | | OTR | | 218,748 | 0 | 0 |
FORUM MERGER IV CORP | CLASS A COM | 349875104 | 9,740 | 1,000,000 | SH | | OTR | | 1,000,000 | 0 | 0 |
FORUM MERGER IV CORP | *W EXP 03/15/202 | 349875112 | 205 | 250,000 | SH | | OTR | | 250,000 | 0 | 0 |
FTAC HERA ACQUISITION CORP | CLASS A ORD SHS | G3728Y103 | 4,885 | 500,000 | SH | | OTR | | 500,000 | 0 | 0 |
FTAC HERA ACQUISITION CORP | *W EXP 02/28/202 | G3728Y111 | 119 | 125,000 | SH | | OTR | | 125,000 | 0 | 0 |
FULL TRUCK ALLIANCE CO LTD | SPONSORED ADS | 35969L108 | 117,245 | 14,007,743 | SH | | OTR | | 14,007,743 | 0 | 0 |
G SQUARED ASCEND I INC | *W EXP 02/01/202 | G4204R117 | 86 | 100,000 | SH | | OTR | | 100,000 | 0 | 0 |
G SQUARED ASCEND I INC | SHS CL A | G4204R109 | 4,940 | 500,000 | SH | | OTR | | 500,000 | 0 | 0 |
GENERATION BIO CO | COM | 37148K100 | 24,780 | 3,500,000 | SH | | OTR | | 3,500,000 | 0 | 0 |
GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 2,531 | 86,454 | SH | | OTR | | 86,454 | 0 | 0 |
GOL LINHAS AEREAS INTELIGENT | SPON ADR PFD NEW | 38045R206 | 519 | 85,838 | SH | | OTR | | 85,838 | 0 | 0 |
GORES HLDGS VIII INC | CL A | 382863108 | 7,067 | 692,810 | SH | | OTR | | 692,810 | 0 | 0 |
GORES HLDGS VIII INC | *W EXP 03/01/202 | 382863116 | 102 | 50,000 | SH | | OTR | | 50,000 | 0 | 0 |
GORES HOLDINGS VII INC | COM CL A | 38286T101 | 11,249 | 1,150,162 | SH | | OTR | | 1,150,162 | 0 | 0 |
GORES HOLDINGS VII INC | *W EXP 02/25/202 | 38286T119 | 128 | 93,750 | SH | | OTR | | 93,750 | 0 | 0 |
GORES METROPOULOS II INC | CL A | 382873107 | 10,967 | 1,100,000 | SH | | OTR | | 1,100,000 | 0 | 0 |
GORES METROPOULOS II INC | *W EXP 01/31/202 | 382873115 | 290 | 150,000 | SH | | OTR | | 150,000 | 0 | 0 |
GORES TECHNOLOGY PARTNERS II | CLASS A COM | 38287L107 | 8,346 | 843,046 | SH | | OTR | | 843,046 | 0 | 0 |
GORES TECHNOLOGY PARTNERS II | *W EXP 03/16/202 | 38287L115 | 157 | 120,000 | SH | | OTR | | 120,000 | 0 | 0 |
GORES TECHNOLOGY PARTNERS IN | CLASS A COM | 382870103 | 4,484 | 452,519 | SH | | OTR | | 452,519 | 0 | 0 |
GORES TECHNOLOGY PARTNERS IN | *W EXP 03/16/202 | 382870111 | 69 | 50,000 | SH | | OTR | | 50,000 | 0 | 0 |
GRIFOLS S A | SP ADR REP B NVT | 398438408 | 596 | 53,133 | SH | | OTR | 1 | 53,133 | 0 | 0 |
GULFPORT ENERGY CORP | COMMON SHARES | 402635502 | 21,348 | 296,372 | SH | | OTR | | 296,372 | 0 | 0 |
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 150,456 | 1,396,217 | SH | | OTR | | 1,396,217 | 0 | 0 |
HELLO GROUP INC | NOTE 1.250% 7/0 | 60879BAB3 | 107,740 | 123,449,000 | PRN | | OTR | | 123,449,000 | 0 | 0 |
HOWMET AEROSPACE INC | COM | 443201108 | 526,196 | 16,531,453 | SH | | OTR | | 16,531,453 | 0 | 0 |
HUDSON EXECUTIVE INVES III | COM CL A | 44376L107 | 2,430 | 250,000 | SH | | OTR | | 250,000 | 0 | 0 |
HUDSON EXECUTIVE INVES III | *W EXP 02/22/202 | 44376L115 | 40 | 50,000 | SH | | OTR | | 50,000 | 0 | 0 |
HUMANCO ACQUISITION CORP | COM CL A | 44487N109 | 13,768 | 1,407,749 | SH | | OTR | | 1,407,749 | 0 | 0 |
HUMANCO ACQUISITION CORP | *W EXP 99/99/999 | 44487N117 | 150 | 200,000 | SH | | OTR | | 200,000 | 0 | 0 |
IKENA ONCOLOGY INC | COM | 45175G108 | 13,560 | 1,081,309 | SH | | OTR | | 1,081,309 | 0 | 0 |
IMAGO BIOSCIENCES INC | COM | 45250K107 | 58,595 | 2,471,313 | SH | | OTR | | 2,471,313 | 0 | 0 |
INFLECTION POINT ACQUSTN COR | CLASS A ORD | G47874121 | 18,316 | 1,900,000 | SH | | OTR | | 1,900,000 | 0 | 0 |
INFLECTION POINT ACQUSTN COR | *W EXP 09/21/202 | G47874113 | 551 | 950,000 | SH | | OTR | | 950,000 | 0 | 0 |
INTERPRIVATE II ACQUISITION | CL A COM | 46064Q108 | 8,562 | 882,647 | SH | | OTR | | 882,647 | 0 | 0 |
INTERPRIVATE II ACQUISITION | *W EXP 09/03/202 | 46064Q116 | 74 | 80,000 | SH | | OTR | | 80,000 | 0 | 0 |
INTERPRIVATE III FINANCIAL P | COM CL A | 46064R106 | 3,964 | 400,000 | SH | | OTR | | 400,000 | 0 | 0 |
INTERPRIVATE IV INFRATECH PR | CLASS A COM | 46064T102 | 5,856 | 600,000 | SH | | OTR | | 600,000 | 0 | 0 |
INTERPRIVATE IV INFRATECH PR | *W EXP 03/05/202 | 46064T110 | 88 | 120,000 | SH | | OTR | | 120,000 | 0 | 0 |
ION ACQUISITION CORP 3 LTD | SHS CL A | G4940J114 | 549 | 56,151 | SH | | OTR | | 56,151 | 0 | 0 |
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 115,723 | 6,061,973 | SH | | OTR | | 6,061,973 | 0 | 0 |
IQIYI INC | NOTE 2.000% 4/0 | 46267XAD0 | 134,106 | 184,662,000 | PRN | | OTR | | 184,662,000 | 0 | 0 |
IQIYI INC | NOTE 4.000%12/1 | 46267XAE8 | 58,216 | 80,300,000 | PRN | | OTR | | 80,300,000 | 0 | 0 |
IQVIA HLDGS INC | COM | 46266C105 | 826,884 | 2,930,756 | SH | | OTR | | 2,930,756 | 0 | 0 |
JAWS MUSTANG ACQUISITION COR | SHS CL A | G50737108 | 7,800 | 800,000 | SH | | OTR | | 800,000 | 0 | 0 |
JAWS MUSTANG ACQUISITION COR | *W EXP 01/30/202 | G50737124 | 206 | 200,000 | SH | | OTR | | 200,000 | 0 | 0 |
JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | 54,912 | 431,021 | SH | | OTR | | 431,021 | 0 | 0 |
JOYY INC | NOTE 0.750% 6/1 | 98426TAD8 | 35,073 | 38,665,000 | PRN | | OTR | | 38,665,000 | 0 | 0 |
JOYY INC | NOTE 1.375% 6/1 | 98426TAF3 | 8,072 | 9,000,000 | PRN | | OTR | | 9,000,000 | 0 | 0 |
KARUNA THERAPEUTICS INC | COM | 48576A100 | 72,050 | 550,000 | SH | | OTR | | 550,000 | 0 | 0 |
KE HLDGS INC | SPONSORED ADS | 482497104 | 28,108 | 1,397,000 | SH | | OTR | | 1,397,000 | 0 | 0 |
KENSINGTON CAPITAL ACQUISITI V | SHS CL A | G5251K103 | 7,620 | 775,200 | SH | | OTR | | 775,200 | 0 | 0 |
KENSINGTON CAPITAL ACQUISITI V | *W EXP 99/99/999 | G5251K129 | 576 | 581,400 | SH | | OTR | | 581,400 | 0 | 0 |
KHOSLA VENTURES ACQUISITION | CL A | 482504107 | 6,790 | 700,000 | SH | | OTR | | 700,000 | 0 | 0 |
KHOSLA VENTURES ACQUT CO III | COM CL A | 482506102 | 27,416 | 2,809,000 | SH | | OTR | | 2,809,000 | 0 | 0 |
KKR ACQUISITION HOLDING I CO | COM CLASS A | 48253T109 | 14,610 | 1,500,000 | SH | | OTR | | 1,500,000 | 0 | 0 |
KKR ACQUISITION HOLDING I CO | *W EXP 99/99/999 | 48253T117 | 374 | 375,000 | SH | | OTR | | 375,000 | 0 | 0 |
LABORATORY CORP AMER HLDGS | COM NEW | 50540R409 | 130,136 | 414,169 | SH | | OTR | | 414,169 | 0 | 0 |
LAMF GLOBAL VENTURES CORP I | UNIT 11/05/2026 | G5338L116 | 4,016 | 400,000 | SH | | OTR | | 400,000 | 0 | 0 |
LANDCADIA HOLDINGS IV INC | CLASS A COM | 51477A104 | 7,812 | 802,028 | SH | | OTR | | 802,028 | 0 | 0 |
LANDCADIA HOLDINGS IV INC | *W EXP 03/29/202 | 51477A112 | 126 | 125,000 | SH | | OTR | | 125,000 | 0 | 0 |
LAZARD GROWTH ACQUISITION CO | CL A ORD SHS | G54035103 | 2,919 | 300,000 | SH | | OTR | | 300,000 | 0 | 0 |
LAZARD GROWTH ACQUISITION CO | *W EXP 02/10/202 | G54035111 | 52 | 60,000 | SH | | OTR | | 60,000 | 0 | 0 |
LDH GROWTH CORP I | CLASS A ORD SHS | G54094100 | 4,288 | 436,702 | SH | | OTR | | 436,702 | 0 | 0 |
LDH GROWTH CORP I | *W EXP 03/17/202 | G54094126 | 23 | 30,000 | SH | | OTR | | 30,000 | 0 | 0 |
LEVERE HOLDINGS CORP | CLASS A ORD SHS | G5462L106 | 7,792 | 800,000 | SH | | OTR | | 800,000 | 0 | 0 |
LEVERE HOLDINGS CORP | *W EXP 03/09/202 | G5462L122 | 195 | 266,667 | SH | | OTR | | 266,667 | 0 | 0 |
LIANBIO | SPONSORED ADS | 53000N108 | 3,696 | 600,000 | SH | | OTR | | 600,000 | 0 | 0 |
LIVE OAK MOBILITY ACQUISI CO | COM CL A | 538126103 | 2,443 | 250,000 | SH | | OTR | | 250,000 | 0 | 0 |
LIVE OAK MOBILITY ACQUISI CO | *W EXP 03/04/202 | 538126111 | 58 | 50,000 | SH | | OTR | | 50,000 | 0 | 0 |
LONGBOARD PHARMACEUTICALS IN | COM | 54300N103 | 3,923 | 810,500 | SH | | OTR | | 810,500 | 0 | 0 |
LONGVIEW ACQUISITION CORP II | COM CL A | 54319Q105 | 2,998 | 304,698 | SH | | OTR | | 304,698 | 0 | 0 |
LONGVIEW ACQUISITION CORP II | *W EXP 99/99/999 | 54319Q113 | 52 | 60,940 | SH | | OTR | | 60,940 | 0 | 0 |
LUFAX HOLDING LTD | ADS REP SHS CL A | 54975P102 | 107,079 | 19,019,399 | SH | | OTR | | 19,019,399 | 0 | 0 |
MARBLEGATE ACQUISITION CORP | COM CL A | 56608A105 | 29,017 | 2,970,000 | SH | | OTR | | 2,970,000 | 0 | 0 |
MARBLEGATE ACQUISITION CORP | *W EXP 08/31/202 | 56608A113 | 735 | 1,485,000 | SH | | OTR | | 1,485,000 | 0 | 0 |
MASTERCARD INCORPORATED | CL A | 57636Q104 | 400,031 | 1,113,300 | SH | | OTR | | 1,113,300 | 0 | 0 |
MERCATO PARTNERS ACQUISITION | UNIT 10/29/2026 | 58759A207 | 7,523 | 750,000 | SH | | OTR | | 750,000 | 0 | 0 |
MERCURY ECOM ACQUISITION COR | CLASS A COM | 589381102 | 16,979 | 1,732,500 | SH | | OTR | | 1,732,500 | 0 | 0 |
MERCURY ECOM ACQUISITION COR | *W EXP 07/27/202 | 589381110 | 424 | 866,250 | SH | | OTR | | 866,250 | 0 | 0 |
META PLATFORMS INC | CL A | 30303M102 | 459,637 | 1,366,545 | SH | | OTR | | 1,366,545 | 0 | 0 |
METALS ACQUISITION CORP | SHS CL A | G60405100 | 23,896 | 2,475,000 | SH | | OTR | | 2,475,000 | 0 | 0 |
METALS ACQUISITION CORP | *W EXP 99/99/999 | G60405126 | 516 | 825,000 | SH | | OTR | | 825,000 | 0 | 0 |
MICROSOFT CORP | COM | 594918104 | 457,825 | 1,361,278 | SH | | OTR | | 1,361,278 | 0 | 0 |
NABORS ENERGY TRANSITION COR | UNIT 99/99/9999 | 629567207 | 9,135 | 900,000 | SH | | OTR | | 900,000 | 0 | 0 |
NATERA INC | COM | 632307104 | 137,537 | 1,472,715 | SH | | OTR | | 1,472,715 | 0 | 0 |
NEW ORIENTAL ED & TECHNOLOGY | SPON ADR | 647581107 | 273 | 130,000 | SH | | OTR | | 130,000 | 0 | 0 |
NEW YORK TIMES CO | CL A | 650111107 | 402,641 | 8,336,258 | SH | | OTR | | 8,336,258 | 0 | 0 |
NIGHTDRAGON ACQUISITION CORP | CLASS A COM | 65413D105 | 11,700 | 1,200,000 | SH | | OTR | | 1,200,000 | 0 | 0 |
NIGHTDRAGON ACQUISITION CORP | *W EXP 02/26/202 | 65413D113 | 70 | 80,000 | SH | | OTR | | 80,000 | 0 | 0 |
NORTHERN STAR INVEST CORP III | COM CL A | 66574L100 | 975 | 100,000 | SH | | OTR | | 100,000 | 0 | 0 |
NORTHERN STAR INVEST CORP III | *W EXP 02/25/202 | 66574L118 | 15 | 16,667 | SH | | OTR | | 16,667 | 0 | 0 |
NORTHERN STAR INVEST CORP IV | COM CL A | 66575B101 | 974 | 100,000 | SH | | OTR | | 100,000 | 0 | 0 |
NORTHERN STAR INVEST CORP IV | *W EXP 02/25/202 | 66575B119 | 14 | 16,666 | SH | | OTR | | 16,666 | 0 | 0 |
NOVUS CAPITAL CORPORATION II | COM CL A | 67012W104 | 8,168 | 825,100 | SH | | OTR | | 825,100 | 0 | 0 |
NOVUS CAPITAL CORPORATION II | *W EXP 02/02/202 | 67012W112 | 292 | 233,333 | SH | | OTR | | 233,333 | 0 | 0 |
NUVATION BIO INC | COM CL A | 67080N101 | 12,155 | 1,430,000 | SH | | OTR | | 1,430,000 | 0 | 0 |
PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 41,851 | 2,045,488 | SH | | OTR | | 2,045,488 | 0 | 0 |
PANACEA ACQUISITION CORP II | CL A SHS | G6882C106 | 7,275 | 750,000 | SH | | OTR | | 750,000 | 0 | 0 |
PATHFINDER ACQUISITION CORP | CL A | G04119106 | 7,275 | 750,000 | SH | | OTR | | 750,000 | 0 | 0 |
PATHFINDER ACQUISITION CORP | *W EXP 02/19/202 | G04119122 | 88 | 150,000 | SH | | OTR | | 150,000 | 0 | 0 |
PERSHING SQUARE TONTINE HLDG | COM CL A | 71531R109 | 19,720 | 1,000,000 | SH | | OTR | | 1,000,000 | 0 | 0 |
PG&E CORP | COM | 69331C108 | 76,544 | 6,305,142 | SH | | OTR | | 6,305,142 | 0 | 0 |
POINT BIOPHARMA GLOBAL INC | COM | 730541109 | 9,555 | 1,706,329 | SH | | OTR | | 1,706,329 | 0 | 0 |
POST HOLDINGS PARTNERING COR | COM SER A | 737465104 | 8,312 | 848,184 | SH | | OTR | | 848,184 | 0 | 0 |
POST HOLDINGS PARTNERING COR | *W EXP 04/12/202 | 737465112 | 227 | 266,666 | SH | | OTR | | 266,666 | 0 | 0 |
PRIVETERRA ACQUISITION CORP | CL A | 74275N102 | 1,458 | 150,000 | SH | | OTR | | 150,000 | 0 | 0 |
PRIVETERRA ACQUISITION CORP | *W EXP 02/28/202 | 74275N110 | 25 | 49,995 | SH | | OTR | | 49,995 | 0 | 0 |
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 65,566 | 1,917,134 | SH | | OTR | | 1,917,134 | 0 | 0 |
QIAGEN NV | SHS NEW | N72482123 | 45,246 | 814,064 | SH | | OTR | | 814,064 | 0 | 0 |
QUANTERIX CORP | COM | 74766Q101 | 23,108 | 545,000 | SH | | OTR | | 545,000 | 0 | 0 |
RADIUS HEALTH INC | COM NEW | 750469207 | 14,583 | 2,107,400 | SH | | OTR | | 2,107,400 | 0 | 0 |
RAYTHEON TECHNOLOGIES CORP | COM | 75513E101 | 497,030 | 5,775,386 | SH | | OTR | | 5,775,386 | 0 | 0 |
RCF ACQUISITION CORP | UNIT 99/99/9999 | G7330C128 | 6,060 | 600,000 | SH | | OTR | | 600,000 | 0 | 0 |
READY CAPITAL CORP | COM | 75574U101 | 16,895 | 1,080,961 | SH | | OTR | | 1,080,961 | 0 | 0 |
REPLIGEN CORP | COM | 759916109 | 36,083 | 136,245 | SH | | OTR | | 136,245 | 0 | 0 |
RESEARCH ALLIANCE CORP II | COM CL A | 760873109 | 7,290 | 750,000 | SH | | OTR | | 750,000 | 0 | 0 |
REVOLUTION HEALTHCAR AQ CORP | CLASS A COM | 76155Y108 | 19,420 | 2,000,000 | SH | | OTR | | 2,000,000 | 0 | 0 |
REVOLUTION HEALTHCAR AQ CORP | *W EXP 12/31/202 | 76155Y116 | 300 | 400,000 | SH | | OTR | | 400,000 | 0 | 0 |
REVOLUTION MEDICINES INC | COM | 76155X100 | 69,218 | 2,750,000 | SH | | OTR | | 2,750,000 | 0 | 0 |
ROCKET INTERNET GRWT OPRT CO | SHS CL A | G7613T103 | 6,350 | 647,945 | SH | | OTR | | 647,945 | 0 | 0 |
ROCKET INTERNET GRWT OPRT CO | *W EXP 99/99/999 | G7613T129 | 95 | 125,000 | SH | | OTR | | 125,000 | 0 | 0 |
RXR ACQUISITION CORP | CLASS A COM | 74981W107 | 8,336 | 854,961 | SH | | OTR | | 854,961 | 0 | 0 |
RXR ACQUISITION CORP | *W EXP 03/08/202 | 74981W115 | 84 | 120,000 | SH | | OTR | | 120,000 | 0 | 0 |
SALESFORCE COM INC | COM | 79466L302 | 283,009 | 1,113,638 | SH | | OTR | | 1,113,638 | 0 | 0 |
SAREPTA THERAPEUTICS INC | COM | 803607100 | 75,553 | 839,009 | SH | | OTR | | 839,009 | 0 | 0 |
SAVARA INC | COM | 805111101 | 9,635 | 7,770,262 | SH | | OTR | | 7,770,262 | 0 | 0 |
SCION TECH GROWTH II | CL A SHS | G31070108 | 4,379 | 450,000 | SH | | OTR | | 450,000 | 0 | 0 |
SCION TECH GROWTH II | *W EXP 01/28/202 | G31070116 | 90 | 150,000 | SH | | OTR | | 150,000 | 0 | 0 |
SDCL EDGE ACQUISITION CORP | CL A ORD SHS | G79471101 | 16,875 | 1,732,500 | SH | | OTR | | 1,732,500 | 0 | 0 |
SDCL EDGE ACQUISITION CORP | *W EXP 99/99/999 | G79471127 | 431 | 866,250 | SH | | OTR | | 866,250 | 0 | 0 |
SERVICENOW INC | COM | 81762P102 | 326,600 | 503,150 | SH | | OTR | | 503,150 | 0 | 0 |
SHELTER ACQUISITION CORP I | CLASS A COM | 822821104 | 16,088 | 1,650,000 | SH | | OTR | | 1,650,000 | 0 | 0 |
SHELTER ACQUISITION CORP I | *W EXP 02/25/202 | 822821112 | 445 | 825,000 | SH | | OTR | | 825,000 | 0 | 0 |
SHERWIN WILLIAMS CO | COM | 824348106 | 334,928 | 951,068 | SH | | OTR | | 951,068 | 0 | 0 |
SLAM CORP | CL A SHS | G8210L105 | 5,561 | 570,396 | SH | | OTR | | 570,396 | 0 | 0 |
SLAM CORP | *W EXP 02/23/202 | G8210L121 | 11 | 17,627 | SH | | OTR | | 17,627 | 0 | 0 |
SOCIAL LEVERAGE ACQUISN CORP | COM CL A | 83363K102 | 7,358 | 750,000 | SH | | OTR | | 750,000 | 0 | 0 |
SOCIAL LEVERAGE ACQUISN CORP | *W EXP 02/17/202 | 83363K110 | 156 | 187,500 | SH | | OTR | | 187,500 | 0 | 0 |
SOLID POWER INC | *W EXP 03/19/202 | 83422N113 | 1,334 | 582,700 | SH | | OTR | | 582,700 | 0 | 0 |
SOMALOGIC INC | CLASS A COM | 83444K105 | 21,056 | 1,808,907 | SH | | OTR | | 1,808,907 | 0 | 0 |
SPARTAN ACQUISITION CORP III | COM CL A | 84677R106 | 593 | 60,053 | SH | | OTR | | 60,053 | 0 | 0 |
SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 788,434 | 1,660,000 | SH | Call | OTR | | 1,660,000 | 0 | 0 |
SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 1,520,347 | 3,201,000 | SH | Put | OTR | | 3,201,000 | 0 | 0 |
SUPERNOVA PARTN ACQ CO III L | SHS CL A | G8T90F102 | 6,825 | 700,000 | SH | | OTR | | 700,000 | 0 | 0 |
SUPERNOVA PARTN ACQ CO III L | *W EXP 99/99/999 | G8T90F128 | 126 | 140,000 | SH | | OTR | | 140,000 | 0 | 0 |
SUPERNOVA PARTNERS ACQUISTN II | SHS CL A | G8T86C105 | 1,827 | 177,580 | SH | | OTR | | 177,580 | 0 | 0 |
SUPERNOVA PARTNERS ACQUISTN II | *W EXP 99/99/999 | G8T86C121 | 119 | 50,000 | SH | | OTR | | 50,000 | 0 | 0 |
SURFACE ONCOLOGY INC | COM | 86877M209 | 2,486 | 520,021 | SH | | OTR | | 520,021 | 0 | 0 |
SVF INVESTMENT CORP | CL A SHS | G8601L102 | 4,267 | 425,000 | SH | | OTR | | 425,000 | 0 | 0 |
SVF INVESTMENT CORP | *W EXP 12/20/202 | G8601L128 | 65 | 50,000 | SH | | OTR | | 50,000 | 0 | 0 |
SWIFTMERGE ACQUISITION CORP | UNIT 12/13/2026 | G63836129 | 19,691 | 1,980,000 | SH | | OTR | | 1,980,000 | 0 | 0 |
TAILWIND TWO ACQUISITION COR | SHS CL A | G86613109 | 9,890 | 1,000,000 | SH | | OTR | | 1,000,000 | 0 | 0 |
TAILWIND TWO ACQUISITION COR | *W EXP 03/09/202 | G86613125 | 282 | 333,333 | SH | | OTR | | 333,333 | 0 | 0 |
TANGO THERAPEUTICS INC | COM | 87583X109 | 3,282 | 300,000 | SH | | OTR | | 300,000 | 0 | 0 |
TCV ACQUISITION CORP | CL A SHS | G8704C124 | 11,945 | 1,211,459 | SH | | OTR | | 1,211,459 | 0 | 0 |
THE MUSIC ACQUISITION CORP | COM CLASS A | 62752R100 | 1,220 | 125,000 | SH | | OTR | | 125,000 | 0 | 0 |
THE MUSIC ACQUISITION CORP | *W EXP 02/05/202 | 62752R118 | 35 | 62,500 | SH | | OTR | | 62,500 | 0 | 0 |
THERMO FISHER SCIENTIFIC INC | COM | 883556102 | 649,197 | 972,959 | SH | | OTR | | 972,959 | 0 | 0 |
THESEUS PHARMACEUTICALS INC | COM | 88369M101 | 6,644 | 523,979 | SH | | OTR | | 523,979 | 0 | 0 |
THUNDER BRIDGE CAP PRTNRS III | COM CL A | 88605T100 | 11,805 | 1,208,326 | SH | | OTR | | 1,208,326 | 0 | 0 |
THUNDER BRIDGE CAP PRTNRS III | *W EXP 02/15/202 | 88605T118 | 125 | 150,000 | SH | | OTR | | 150,000 | 0 | 0 |
TIGA ACQUISITION CORP | SHS CL A | G88672103 | 10,943 | 1,080,000 | SH | | OTR | | 1,080,000 | 0 | 0 |
TIGA ACQUISITION CORP | *W EXP 11/06/202 | G88672111 | 383 | 540,000 | SH | | OTR | | 540,000 | 0 | 0 |
TIO TECH A | CLASS A ORD SHS | G8T10C106 | 4,859 | 502,001 | SH | | OTR | | 502,001 | 0 | 0 |
TIO TECH A | *W EXP 04/12/202 | G8T10C114 | 146 | 166,666 | SH | | OTR | | 166,666 | 0 | 0 |
TPG PACE BENEFICIAL II CORP | COMMON STOCK | G89826104 | 10,945 | 1,116,833 | SH | | OTR | | 1,116,833 | 0 | 0 |
TRANSUNION | COM | 89400J107 | 330,741 | 2,789,182 | SH | | OTR | | 2,789,182 | 0 | 0 |
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 69,310 | 320,760 | SH | | OTR | | 320,760 | 0 | 0 |
UTA ACQUISITION CORPORATION | UNIT 12/01/2026 | G9473A125 | 3,518 | 350,000 | SH | | OTR | | 350,000 | 0 | 0 |
VECTOR ACQUISITION CORP II | CL A SHS | G9460A104 | 16,609 | 1,700,000 | SH | | OTR | | 1,700,000 | 0 | 0 |
VENTYX BIOSCIENCES INC | COM | 92332V107 | 22,130 | 1,114,280 | SH | | OTR | | 1,114,280 | 0 | 0 |
VERACYTE INC | COM | 92337F107 | 7,876 | 191,158 | SH | | OTR | | 191,158 | 0 | 0 |
VIRGIN GROUP ACQUISIT CORP I | SHS CL A | G9460K102 | 9,870 | 1,000,000 | SH | | OTR | | 1,000,000 | 0 | 0 |
VIRGIN GROUP ACQUISIT CORP I | *W EXP 03/13/202 | G9460K128 | 168 | 200,000 | SH | | OTR | | 200,000 | 0 | 0 |
VISA INC | COM CL A | 92826C839 | 306,559 | 1,414,604 | SH | | OTR | | 1,414,604 | 0 | 0 |
VMG CONSUMER ACQUISITION COR | UNIT 11/08/2026 | 91842V201 | 3,553 | 350,000 | SH | | OTR | | 350,000 | 0 | 0 |
VPC IMPACT ACQU HOLDI III IN | COM CL A | 91835J108 | 6,150 | 600,000 | SH | | OTR | | 600,000 | 0 | 0 |
VPC IMPACT ACQU HOLDI III IN | *W EXP 09/03/202 | 91835J116 | 124 | 100,000 | SH | | OTR | | 100,000 | 0 | 0 |
VPC IMPACT ACQUISITION HLDG II | CLASS A ORD | G9460L126 | 4,169 | 425,000 | SH | | OTR | | 425,000 | 0 | 0 |
VPC IMPACT ACQUISITION HLDG II | *W EXP 03/05/202 | G9460L118 | 105 | 106,250 | SH | | OTR | | 106,250 | 0 | 0 |
WABTEC | COM | 929740108 | 574,872 | 6,241,151 | SH | | OTR | | 6,241,151 | 0 | 0 |
WARBURG PINCUS CAPTAL CORP I-A | SHS CL A | G9461D107 | 10,977 | 1,120,102 | SH | | OTR | | 1,120,102 | 0 | 0 |
WARBURG PINCUS CAPTAL CORP I-A | *W EXP 99/99/999 | G9461D115 | 146 | 150,000 | SH | | OTR | | 150,000 | 0 | 0 |
WARBURG PINCUS CAPTAL CORP I-B | SHS CL A | G9460M108 | 7,320 | 750,000 | SH | | OTR | | 750,000 | 0 | 0 |
WARBURG PINCUS CAPTAL CORP I-B | *W EXP 99/99/999 | G9460M124 | 155 | 150,000 | SH | | OTR | | 150,000 | 0 | 0 |
ZEALAND PHARMA A/S | SPONSORED ADR | 98920Y304 | 10,883 | 510,000 | SH | | OTR | | 510,000 | 0 | 0 |
ZENDESK INC | COM | 98936J101 | 44,845 | 430,000 | SH | | OTR | | 430,000 | 0 | 0 |
ZOGENIX INC | COM NEW | 98978L204 | 44,963 | 2,766,935 | SH | | OTR | | 2,766,935 | 0 | 0 |